Methamphetamine Use Disorder Treatment in San Diego: What the First Few Weeks Actually Look Like

Methamphetamine is one of the most common reasons people walk through the door of a San Diego treatment center, and it is also one of the least well understood. Families often arrive expecting something that looks like an opioid or alcohol detox: a dramatic physical crisis, a week of medication, then improvement. Stimulant recovery rarely follows that shape. The first few weeks are quieter, slower, and in some ways harder to sit through, which is exactly why so many people leave before the part that helps begins.

This is a plain description of what those weeks tend to involve, what treatment actually does during them, and how to think about levels of care if you or someone you love is trying to decide what comes next.

Why Stimulant Withdrawal Gets Underestimated

Withdrawal from methamphetamine is not usually medically dangerous on its own, and that fact gets misread as “not serious.” What it produces instead is a period of profound depletion. People describe sleeping for enormous stretches, waking confused about what day it is, and then feeling almost nothing at all for a while afterward. Motivation flattens. Food tastes like nothing. Things that used to be interesting are simply not interesting.

Clinically, that flatness has a name and a mechanism, and the National Institute on Drug Abuse maintains accessible overviews of how chronic stimulant use affects the brain’s reward and dopamine systems and how those systems recover over time. The practical takeaway matters more than the neuroscience: the low mood of early stimulant recovery is a predictable stage, not a verdict on whether someone can get better.

There is one important exception to the “not medically dangerous” rule. Many people who use methamphetamine also use alcohol or benzodiazepines to come down and sleep. Withdrawal from either of those substances can cause seizures and can be life-threatening, and it requires medically supervised detox — not a plan to stop at home. An honest intake assessment asks about every substance, in what amount, and how recently, precisely because that combination changes the medical picture completely.

The First Seventy-Two Hours

The opening days of a stimulant detox are mostly about sleep, hydration, and food. Nursing staff check vital signs, watch blood pressure and heart rate, and track how much someone is actually eating and drinking. Dental pain, skin infections, and untreated wounds surface often and get addressed early because they are genuinely uncomfortable and because ignoring them gives people a concrete reason to leave.

Medication in this phase is targeted rather than protocol-driven: something for sleep, something for nausea, something for agitation or anxiety if it is severe. There is no equivalent of buprenorphine for methamphetamine. Clinicians are treating symptoms and keeping someone comfortable enough to stay, not administering a taper.

Expectations should be modest here. Very little therapeutic work happens in the first three days, and good programs do not force it. Someone who is sleeping eighteen hours a day is not retaining a lecture on relapse prevention. The goal of this stretch is simply that the person is still there on day four.

Week Two, When People Most Often Leave

The second and third weeks are the part nobody warns families about. Sleep normalizes somewhat, energy returns unevenly, and the emotional flatness becomes fully noticeable. People often feel worse psychologically in week two than they did in week one, and they reliably interpret that as evidence treatment is not working.

Cravings in this window are frequently triggered by boredom rather than distress — an ordinary afternoon with nothing scheduled is far more dangerous than a hard therapy session. This is one reason structured programs pack the day with groups, individual sessions, exercise, and meals at set times. The structure is not busywork; it is a substitute for a reward system that is temporarily offline.

Being told in advance that this phase is coming changes how people respond to it. Someone who has been told “around day ten you will probably feel flat and want to leave, and that is the stage, not the outcome” tends to stay through it. Someone who has not been told assumes the flatness is permanent.

What Treatment Uses When There Is No Approved Medication

There is currently no medication approved by the U.S. Food and Drug Administration specifically for methamphetamine use disorder. Treatment therefore leans on behavioral approaches with an established evidence base, and the Substance Abuse and Mental Health Services Administration publishes practitioner guidance on stimulant use disorder that programs draw from.

In practice that usually means several things working together: contingency management, which provides structured tangible reinforcement for verified periods of abstinence and has the strongest research support of any stimulant-specific intervention; cognitive behavioral therapy focused on identifying the situations and internal states that precede use; motivational interviewing, especially early, when ambivalence is high; and consistent involvement in a recovery community, whether that is a twelve-step group, SMART Recovery, or a program alumni network.

Medications still have a role, just an indirect one — treating depression, anxiety, ADHD, or a sleep disorder that is making everything harder. That is different from treating the stimulant use disorder itself, and a good clinician will be clear about which is which rather than implying a prescription is the fix.

When Psychiatric Symptoms Are Part of the Picture

Heavy or prolonged methamphetamine use can produce paranoia, hallucinations, and profound insomnia, and these symptoms sometimes persist well past the point when the substance has cleared. Distinguishing a stimulant-induced psychiatric syndrome from an independent condition takes time and repeated observation — it is generally not something anyone can settle accurately during intake week.

That uncertainty is an argument for integrated care rather than sequential care. Programs offering dual diagnosis treatment in San Diego assess mental health alongside substance use from the start and revise the picture as it becomes clearer, instead of sending someone to a separate provider months later. The American Society of Addiction Medicine’s criteria for level-of-care decisions likewise treat mental health status as a core dimension, not an afterthought.

Choosing a Level of Care

Level of care is a clinical decision, but the reasoning behind it is straightforward. Residential treatment tends to fit people whose living situation includes active use, who have significant psychiatric symptoms, who have tried outpatient care unsuccessfully, or who have no realistic way to fill unstructured time. The value of residential care for stimulant recovery is largely the value of removing choice during the weeks when choosing well is hardest.

Partial hospitalization and intensive outpatient programs work better for people with stable, substance-free housing and something to preserve — a job, custody arrangements, school. Many people step down through these levels rather than choosing between them, and stepping down at the right moment matters as much as starting at the right one.

One caution specific to stimulants: because withdrawal is not dramatic, people sometimes assume they can skip straight to a weekly therapy appointment. That underestimates how much of the risk lives in unstructured time rather than in physical symptoms.

The Overdose Risk Nobody Expects

The illicit stimulant supply is no longer reliably just stimulants. Illicitly manufactured fentanyl has turned up in counterfeit pills and in powders sold as other substances, and public health agencies including the Centers for Disease Control and Prevention have issued ongoing guidance about contamination and overdose risk. People who do not consider themselves opioid users can and do experience opioid overdoses.

The practical response is unglamorous and worth doing anyway: keep naloxone available, know how to use it, and never use alone. Ask any program you are considering whether they send families home with naloxone and train them on it. Call (619) 350-8220 if you want to talk through what that looks like for your household.

What to Ask Before Admission

A few questions separate programs that have thought about stimulant recovery from programs that treat every substance the same way. Do you use contingency management, and how is it structured? What does the daily schedule look like in weeks two and three specifically? How do you handle a psychiatric evaluation when symptoms may be substance-induced? What is the aftercare plan, and who is responsible for making the first appointment? A program that answers these concretely is telling you something useful.

Recovery from methamphetamine use disorder is realistic, and outcomes improve with longer engagement in care. It is also slower to feel good than most people are told, and knowing that in advance is protective. If you are weighing options in San Diego and want a straight answer about what level of care fits, call (619) 350-8220 to speak with the admissions team.

This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Individual circumstances vary, and treatment decisions should be made with a licensed medical or behavioral health professional. Withdrawal from alcohol or benzodiazepines can be life-threatening and requires medical supervision. If you are experiencing a medical or mental health emergency, call 911. The 988 Suicide and Crisis Lifeline is available 24 hours a day by calling or texting 988.

References and further reading:
National Institute on Drug Abuse — Methamphetamine;
SAMHSA — Substance Use Treatment;
American Society of Addiction Medicine — The ASAM Criteria;
CDC — Overdose Prevention.